Type 2 diabetes mellitus

ABCD Consultant Development Programme (CDP) 2023

Event

Taxonomy

ABCD Diabetes Type 1 diabetes mellitus Type 2 diabetes mellitus UK

Empagliflozin Reduced the Total Burden of Events Leading to or Prolonging Hospitalisation in EMPA-REG OUTCOME

Resource

Taxonomy

Current Diabetes Treatments for diabetes Type 2 diabetes mellitus Posters

Service evaluation of Diabetes Structured Education in Kent and Medway

Resource

Taxonomy

Current Diabetes Type 2 diabetes mellitus Posters Education

On Demand webinar: What should the ideal service for complex and severe obesity look like?

Resource

Taxonomy

Current Diabetes Endocrinology Obesity Obesity Type 2 diabetes mellitus Webinar

Development of a binomial logistic regression model for non-invasive prediction of Type 2 Diabetes

Resource

Taxonomy

Current Diabetes Treatments for diabetes Type 2 diabetes mellitus Posters

A step towards precision nutrition in participants with Type 2 Diabetes: A self-completed questionnaire-based study

Resource

Taxonomy

Current Diabetes Treatments for diabetes Type 2 diabetes mellitus Posters

Impact of Semaglutide on Body Composition in Adults with Overweight or Obesity: Exploratory Analysis of the STEP 1 Study

Resource

Taxonomy

Current Diabetes Obesity Treatments for diabetes Type 2 diabetes mellitus Posters

The impact of empagliflozin dose on HbA1c & weight outcomes at 6 & 12 months: updated analysis from the ABCD empagliflozin audit programme

Resource

Taxonomy

Audit Current Diabetes Treatments for diabetes Type 2 diabetes mellitus Posters

Once-Weekly Semaglutide 2.4 mg Improved Glucose Metabolism and Prediabetes in Adults with Overweight/Obesity in the STEP 1 Trial

Resource

Taxonomy

Current Diabetes Obesity Type 2 diabetes mellitus Posters

Characteristics of patients with SGLT2 inhibitors associated DKA between 2008 and 2020: a case series from King’s College Hospital

Resource

Taxonomy

Current Diabetes DKA Treatments for diabetes Type 2 diabetes mellitus Posters

Treatment with Once-Weekly Semaglutide 2.4 mg Improves Cardiometabolic Risk Factors in Adults with Overweight/Obesity and Type 2 Diabetes: STEP 2 Post-hoc Analysis

Resource

Taxonomy

Cardiovascular Current Diabetes Treatments for diabetes Type 2 diabetes mellitus Posters

How will recent developments in obesity management change obesity services

Resource

Taxonomy

Current Diabetes Endocrinology Obesity Obesity Type 2 diabetes mellitus Webinar

Subscribe to The Association of British Clinical Diabetologists